Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 6 (2024) Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy Abstract  similar documents
D. V. Zakharov, D. D. Kokareva
"... Depression and sialorrhea are among the most common and distressing non-motor symptoms ..."
 
Vol 2, No 4 (2010) Depression in Parkinson's disease Abstract  similar documents
M. R. Nodel'
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..."
 
Vol 12, No 5 (2020) On the heterogeneity of depression in Parkinson’s disease Abstract  similar documents
M. R. Nodel, N. N. Yakhno
"... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..."
 
Vol 11, No 2 (2019) Pathogenesis, clinical features, and treatments of depression in Parkinson's disease Abstract  similar documents
I. V. Milyukhina
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..."
 
Vol 9, No 4 (2017) Neuropsychological pattern of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..."
 
Vol 12, No 5 (2020) The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease Abstract  similar documents
I. V. Miliukhina
"... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..."
 
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
M. R. Nodel
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..."
 
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
M. R. Nodel
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..."
 
Vol 15, No 3 (2023) Parkinson’s disease. Focus on early stages Abstract  similar documents
E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova
"... in the early stages of Parkinson’s disease (PD) and considers the hypothesis of the presence of body-first ..."
 
Vol 5, No 2 (2013) The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms Abstract  similar documents
E N Gubanova, Natalia Vladimirovna Fedorova
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..."
 
Vol 14, No 4 (2022) Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease Abstract  similar documents
E. V. Yakovenko, F. A. Abbasov
"... Mental and cognitive impairments are common non-motor symptoms of Parkinson's disease (PD), which ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 11, No 3 (2019) The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases Abstract  similar documents
I. V. Miliukhina
"... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..."
 
Vol 3, No 3 (2011) Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) Abstract  similar documents
M. R. Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..."
 
Vol 10, No 4 (2018) Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease Abstract  similar documents
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..."
 
Vol 13, No 4 (2021) IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy Abstract  similar documents
A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko
"... Sialorrhea is a severe medical problem that is difficult to treat, which can lead to serious ..."
 
Vol 14, No 1 (2022) Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease Abstract  similar documents
D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh
"... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. Consequently, there has ..."
 
Vol 14, No 2 (2022) Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea Abstract  PDF (Eng)  similar documents
A. L. Kurenkov, L. M. Kuzenkova, B. I. Bursagova, V. V. Chernikov, O. V. Agranovich, L. G. Khachatryan, V. M. Kenis, V. A. Zherebtsova, M. N. Sarzhina, N. D. Odinaeva, A. R. Artemenko, G. A. Popova, E. A. Moroshek, E. E. Tabe, A. A. Nezhelskaya, A. A. Maksimenko, L. Ya. Akhadova, M. V. Indereikin, N. V. Duibanova, L. V. Tikhonova, A. V. Sapogovskiy, Z. M. Gadzhialieva, A. V. Grigorieva, V. S. Perminov, I. D. Fedonyuk, L. M. Kolpakchi, A. Yu. Kursakova, N. A. Tsurina
"... , as well as sialorrhea in patients with CP. The article also provides a consensus opinion of Russian ..."
 
Vol 17, No 2 (2025) Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke Abstract  similar documents
V. V. Gusev, T. V. Balueva, O. V. Zayceva, D. A. Smirnov
"... Dysphagia and sialorrhea are common complications of stroke that worsen quality of life ..."
 
Vol 16, No 3 (2024) Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries Abstract  similar documents
E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova
"... The review addresses an approach to the treatment of early stages of Parkinson's disease (PD ..."
 
Vol 9, No 1 (2017) The genetic basis of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..."
 
Vol 8, No 4 (2016) HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE Abstract  similar documents
M. R. Nodel
"... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..."
 
Vol 6, No 4 (2014) The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) Abstract  similar documents
M. R. Sapronova, N. A. Shnaider
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..."
 
Online-first Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease at a young age Abstract  similar documents
D. V. Artemyev
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
M. R. Nodel', N. N. Yakhno
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..."
 
Vol 4, No 1 (2012) Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..."
 
Vol 11, No 2 (2019) Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease Abstract  similar documents
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..."
 
Vol 6, No 4 (2014) Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease Abstract  similar documents
V. L. Golubev, A. B. Kamakinova
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..."
 
Vol 15, No 3 (2023) Vitamin B12 deficiency and Parkinson’s disease Abstract  similar documents
Z. A. Zalyalova, E. V. Ekusheva
"... Parkinson’s disease (PD) is a progressive neurodegenerative disease with various clinical ..."
 
Vol 12, No 1 (2020) Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova
"... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..."
 
Vol 10, No 4 (2018) Approaches to therapy for depressions in neurology: prospects for the use of agomelatine Abstract  similar documents
D. V. Romanov, B. A. Volel, D. S. Petelin
"... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington ..."
 
Vol 5, No 2 (2013) Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures Abstract  similar documents
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
Vol 13, No 6 (2021) Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease Abstract  similar documents
E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova
"... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..."
 
Vol 7, No 3 (2015) Experience in using levodopa-benserazide Abstract  similar documents
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..."
 
Vol 9, No 3 (2017) Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..."
 
Vol 16, No 2 (2024) Efficacy of antiparkinsonian therapy in tremor correction according to tremorography Abstract  similar documents
V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov
"... the frequency-amplitude characteristics in the correction of tremulous hyperkinesis in Parkinson's disease (PD ..."
 
Vol 15, No 1 (2023) The gut microbiome as a factor in the development of Parkinson's disease Abstract  similar documents
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov
"... Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive death ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..."
 
Vol 15, No 6 (2023) Effect of dopaminergic therapy on lacrimation in Parkinson's disease Abstract  similar documents
A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk
"... The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads ..."
 
Vol 11, No 3 (2019) The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..."
 
Vol 15, No 2 (2023) The use of antidepressants in neurological practice Abstract  similar documents
V. A. Parfenov
"... 's disease, depression with cognitive impairment, Parkinson's disease, multiple sclerosis, chronic back pain ..."
 
Vol 14, No 6 (2022) A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study Abstract  similar documents
Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova
"... effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine ..."
 
Vol 12, No 6 (2020) Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease Abstract  similar documents
I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova
"... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease Abstract  similar documents
I. G. Tishkova, I. S. Preobrazhenskaya
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..."
 
Vol 3, No 4 (2011) Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease Abstract  similar documents
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..."
 
Vol 16, No 3 (2024) Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem) Abstract  similar documents
Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, S. N. Illarioshkin
"... Psychotic disorders in Parkinson's disease (PD) are common non-motor manifestations that have ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..."
 
Vol 13, No 4 (2021) Treatment of antipsychotic-induced parkinsonism in schizophrenic patients Abstract  similar documents
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... siblings, one of whom is observed to have parkinsonism with ALS syndrome; and the other had Parkinson ..."
 
Vol 13, No 3 (2021) Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis Abstract  similar documents
A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider
"... В лечении болезни Паркинсона (БП) используются пять групп противопаркинсонических препаратов ..."
 
Vol 12, No 5 (2020) NMDA receptor antagonists in the treatment of neurological diseases Abstract  similar documents
I. S. Preobrazhenskaya
"... disorders with NMDA receptor antagonists in Parkinson's disease, traumatic brain injury, and some other ..."
 
Vol 12, No 4 (2020) The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects Abstract  similar documents
R. G. Akzhigitov, K. I. Pochigayeva, F. K. Rider, A. M. Teplyshova, S. I. Dedayev, I. A. Shpak, E. V. Pashnin, A. B. Gekht
"... , Parkinson's disease, depression, schizophrenia, dementia, etc. There are data of the largest-scale ..."
 
Vol 16, No 4 (2024) Difficulties in the diagnosis of depression in somatic and neurological practice: clinical observation Abstract  similar documents
N. A. Tyuvina, T. N. Maximova, S. V. Prokhorova, E. A. Kamelina
"...    Депрессия довольно часто развивается на фоне соматической и неврологической патологии, но ..."
 
Vol 1, No 2 (2009) DEPRESSION IN CEREBROVASCULAR DISEASES Abstract  similar documents
T. G. Voznesenskaya
"... Обсуждается актуальная проблема депрессии при цереброваскулярных заболеваниях. Приводятся ее ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Cognitive reserve and cognitive impairments: drug and nondrug treatments Abstract  similar documents
E.I. Dainikova, N.V. Pizova
"... and Parkinson's disease, are covered. The issues of correcting CIs in cerebrovascular and neurodegenerative ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Vascular depression and cognitive dysfunction Abstract  similar documents
A. N. Bogolepova
"... Сосудистая депрессия является весьма частым и серьезным осложнением цереброваскулярных заболеваний ..."
 
Vol 9, No 3 (2017) A chronobiological approach to therapy for depression Abstract  similar documents
M. Yu. Gerasimchuk
"... генетической предрасположенности повышает риск возникновения и хронизации депрессии. Для решения этой проблемы ..."
 
Vol 1, No 3-4 (2009) DEPRESSION AND CARDIOVASCULAR DISEASES Abstract  similar documents
L. V. Romasenko
"... По результатам комплексной оценки больных кардиологического стационара, страдающих депрессией ..."
 
1 - 70 of 263 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)